Together, these findings demonstrate that ANT2 mediates the effects of CKIε on cell growth and CKIε-selective inhibition reduces ANT2 level in mitochondria and renders ovarian cancer cells more susceptible to chemotherapeutic agents. The gene discussed is CSNK1E; the disease is ovarian carcinoma.